In recent years economists have been taking an increasing interest in the evaluation of health expenditures. One technique used has been costbenefit analysis, which attempts to evaluate as exhaustively as possible the costs and benefits of the implementation of investment projects, usually in the public sector of the economy. Cost-benefit studies have looked, for example, at cancer, tuberculosis, and poliomyelitis (Weisbrod, 1961) , mental health (Fein, 1958) , syphilis (Klarman, 1965) , and alcoholism (Holtmann, 1963 ). An American study (U.S. Department of Health, Education, and Welfare, 1966) has carried out cost-benefit calculations in arthritis (covering osteoarthritis, rheumatoid arthritis, and gout). The present paper is a preliminary cost-benefit investigation in the treatment of rheumatic diseases.
Material and Methods
The analysis was based on work carried out at the Centre for Rheumatic Diseases (CRD), Glasgow. This is a self-contained 48-bed hospital under the Board of Management of the Glasgow Royal Infirmary. The study was confined to an assessment of the costs and benefits of the treatment of 366 in-patients who entered the CRD in the year April, 1965, to March, 1966 .
Costs
The published cost per patient-week figure, given in the Statement of Accounts and Statistics of the Western Regional Hospital Board and Constituent Boards of Management for Year Ended 31 March, 1966, was inadequate for the purposes of cost-benefit analysis. For example, certain laboratory tests were carried out for the CRD by the Royal Infirmary, as were x-ray examinations. Part of the costs of these facilities had to be apportioned to the CRD. Capital costs had to be estimated and included. In addition, 119 operations were carried out on the 366 patients; since most of these operations took place at other hospitals it was necessary to cost them. All the additional cost categories are given later in Table VII. Since out-patient costs for hospitals of the size of the CRD are not normally assessed separately from inpatient costs, an estimate was made of out-patient costs. This was then deducted from the total cost figure in order to give an in-patient cost figure which could be compared with in-patients benefits figures obtained.
Benefits
The 366 patients were arranged in five categories (see Table I ). For the assessment of benefits patients were interviewed after their period of hospitalization with a view to discovering the results of treatment. For those who could be expected to be employed questions were asked of the time they lost from work before and after their in-patient stays and the dates of their returns to work (if they did). In addition, the earnings of each person were noted. For the Housewives category, questions were asked of each housewife as to her-ability to do housework before and after her in-patient stay. It was clear that, primarily for time reasons, all these patients could not possibly be interviewed. The following procedures were therefore adopted:
(1) The Old People category was excluded from the study.
(2) A sample of patients in the Housewives category was taken. For a variety of reasons the number of housewives from which the sample was taken was reduced to 140. A random sample of 35 was chosen from this group of 140 using a random numbers table. In the event it proved possible to see only 26 of the sample of 35 patients. This was a disappointingly low figure. It is probably reasonable, however, to infer that a similar proportion of non-respondence would have occurred in the population of 140 housewives. Table  II gives the age distribution of the Housewives sample. The majority (69 per cent.) of the sample had rheumatoid arthritis. The estimation of benefits for this category of patient was carried out on the basis of replies in interviews with the 26 patients seen. (ii) The earnings figures for each successful patient were assumed to increase at real rates (that is, after allowing for inflation) of 1, 2, 3, and 4 per cent. per annum.
(iii) Discount rates of 5 and 8 per cent. were applied to the earnings figures obtained at step (ii). Benefits accrue as a flow over a period of time. In order to put these benefits on a present-value basis (present-value for year April, 1965, to March, 1966) discount rates were applied to the earnings figures. The higher the discount rate, the lower the discounted present-value. The formula used was:
(I+iYn where bo=benefits in year 0 (April, 1965 , to March, 1966 .
bl=benefits in year 1 (April, 1966 , to March, 1967 . and so on up to bn. n =number of years benefits expected to accrue. i =discount rate (i = either 5 or 8 per cent.).
(iv) Discounted benefits for each male were totalled in each year to give an overall benefits figure for the category for the year. The overall benefits were then aggregated over 5-year periods. It proved necessary to make certain additional cost estimates for patients whose in-patient stays overlapped into the year April, 1966, to March, 1967, or who made further stays in this year for additional operations. These costs amounted to £4,212. The total cost figure therefore was £95,811 +£4,212 , that is £100,023.
Costs were further broken down to give figures for each patient category, in order to facilitate comparison with benefits in each patient category (see Table VIII ). Calculations for periods beyond the 10-year total were carried out.
Costs for the Males category were £12,366 (Table VIII) . Table IX shows that, under all assumptions of real earnings, and growth rates and with either discount rate used, benefits exceed costs. Even under the most pessimistic assumptions, that all the patients will have ceased work by the end of 5 years, that real earnings will increase by 1 per cent. per annum, and using the higher discount rate, benefits (£65,882) exceed costs (£12,366) by £53,516. Females.-The cost figure for the Femalescategory was £9,797 (see Table VIII ). Benefits for this category are summarized in Table X . Benefits accrued to six out of 33 patients, three with rheumatoid arthritis, one polyarthritis, one systemic lupus erythematosus, and one intervertebral disc degeneration). There were three synovectomies, one patellectomy, one laminectomy, and one knee exploration (this appeared to be a "placebo effect" case).
COMPARISON OF BENEFITS WITH COSTS (FEMALES)
Table X shows that the lowest benefits figure is £18,021, which is greater than costs (£9,797) for this category.
Housewives.-Costs for the Housewives category amounted to £37,544 (see Table VIII One of the most important drawbacks to the study of health expenditures in a cost-benefit manner is the problem of the multiplicity of variables. Pre- cisely what effect does a particular health programme or set of health facilities have on the health of a population? Economists are agreed that much more work must be done on this particular problem before the precise influence of health expenditure will become apparent. The present study is no exception to the general rule, that variables other than health may have distorted the figures given.
Discussion about the choice of the benefits criterion is undoubtedly required. The decision to use the successful operations criterion was taken on the grounds that synovectomy seemed to be proving medically successful in the sense of relieving joint pain. Synovectomy follow-up studies are in process which may confirm this. Since 74 out of 119 operations carried out on the 366 CRD patients studied were synovectomies, it appeared worthwhile to interview patients with a view to discovering whether these operations had returned them to work or to housework. In those cases regarded as "successful" in this study, synovectomies (or other types of operation) were given as the reason for return to work. On this rather narrow, if subjective, criterion, very few patients among those actually interviewed were success cases (22 out of 1 5 patients interviewed, thirty of whom were operated on). Nevertheless, benefits exceeded costs and it is cleat that, if synovectomy, for example, is the instrumental factor in enabling patients to return to work, then considerable economic benefits ensue. However, virtually no mention so far has been made of other forms of treatment, such as drugs.
Can the administration of drugs enable a return to work? In individual patient cases this may be so. However, the measurement of the effectiveness of drugs has problems associated with it. For example, it was found from interviewing patients in this study that many of them had either had the dosage of particular drugs changed or the type of drug changed over a period of time. This made it difficult to assess the help a person was obtaining from the use of drugs. Clearly problems of this type have to be surmounted by the construction and implementation of medical trials. The economic effectiveness of such trials may well be a subject for future study. It was decided in the current study not to attempt measurement of the benefits accruing from drug treatment.
The possibility of looking from an economic point of view at the results of medical trials, at the success or otherwise of different types of operation, at the effectiveness of such methods of treatment as physiotherapy, leads to more positive conclusions to be drawn about cost-benefit analysis, or at any rate, economic analysis in the field of expenditure on rheumatic diseases. Whatever may be said about the tendency of economists to concentrate solely on the economic effects of health treatment, to the exclusion of (perhaps more important) non-economic effects, it should be realized that important resource allocation decisions have to be made in the health expenditure field as with any other form of expenditure. If the economist can show the different economic effects of different types of treatment and different types of facilities, both within the rheumatic diseases field and within the health sector generally, then health administrators and medical personnel will have more information on which to base the decisions they have to take. Consequently it is hoped that methods of decision-taking will improve. Cost-benefit analysis is one of the ways in which economists can help to provide the required information. This paper has aimed at giving an indication of the possibilities for this type of analysis in the field of rheumatic diseases.
Summary
(1) A preliminary attempt has been made tco assess the costs and benefits of the treatment of rheumatic diseases, based on an analysis of the in-patients treated at the Centre for Rheumatic Diseases, Glasgow, in the year April, 1965 , to March, 1966 ( 2) (4) El criterio usado en cuanto a beneficios fue el retorno al trabajo como resultado de una operacion (en la categoria de hombres y mujeres), o recuperacion de la aptitud para realizar tareas caseras (en la categoria de amas de casa). La medida de los beneficios, usada en estos casos, fue: rentas (hombres y mujeres) o costo de ayuda domestica (amas de casa). Aplicando promedios de aumento de salarios actuales a las cifras de rentas (ingresos) y luego descontando estas cifras al 5 y 8 por ciento para compensar el aumento que experimentan los beneficios acumulados a lo largo de determinado periodo. se obtuvieron cifras de beneficios descontadas. Estos, beneficios agregados fueron calculados en varios periodos de enfermedad.
(5) Los beneficios fueron comparados con los costos en cada categoria de pacientes, y los beneficios totales fueron, entonces, comparados con los costos totales. Se demostr6 que el valor actual neto era positivo (el valor actual de los beneficios excedia el valor actual de los costos) en todas las circunstancias imaginadas para calcular las cifras de beneficios.
(6) Se lleg6 a la conclusion de que existia un caso de economia prima facie, que justificaba la inversi6n de recursos destinados al tratamiento de las enfermedades reumiticas. Se discutieron los elementos que habilitaban esta conclusi6n.
